Results 51 to 60 of about 15,279 (219)
A clinical case of exocrine pancreatic insufficiency in a patient with type 1 diabetes mellitus
The pancreas belongs to the glands of mixed secretion and simultaneously performs both endo- and exocrine functions. Exocrine pancreatic insufficiency (EPI) is the general name for the malabsorption process caused by inadequate production and decreased ...
M. R. Ragimov +4 more
doaj +1 more source
Abstract The GLIM malnutrition diagnostic framework includes the etiologic criterion for reduced dietary intake or assimilation (i.e., digestion or absorption). This criterion required further specification to support consistent use in clinical practice.
Renée Blaauw +28 more
wiley +1 more source
Myeloid sarcoma presenting as an isolated pancreatic mass in a 3‐year‐old child
Abstract Myeloid sarcoma (MS) is an extramedullary tumor of myeloid precursor cells, frequently associated with acute myeloid leukemia (AML), and rarely occurring in isolation. We present a child with obstructive jaundice secondary to a pancreatic head mass.
Jappmann Kaur Monga +7 more
wiley +1 more source
Shwachman-Diamond syndrome (SDS) is a rare autosomal recessive disease characterized by bone marrow dysfunction, exocrine pancreatic insufficiency and skeletal abnormalities. Persistent or intermittent neutropenia caused by bone marrow hypoplasia is the
Dilvin Çelik Ateş +3 more
doaj +1 more source
Pancreas—Its Functions, Disorders, and Physiological Impact on the Mammals’ Organism
This review aimed to analyze the scientific literature on pancreatic diseases (especially exocrine pancreatic insufficiency). This review also describes the correlation between the physiological fitness of the pancreas and obesity.
Monika Karpińska, Marian Czauderna
doaj +1 more source
ABSTRACT Background and Objectives To evaluate the prognostic significance of baseline and longitudinal changes in prognostic nutritional index (PNI) in localized pancreatic ductal adenocarcinoma (PDAC) and to assess the complementary prognostic value of PNI with tumor burden measured by circulating tumor DNA (ctDNA).
Alex Horowitz +9 more
wiley +1 more source
Understanding pancreatic exocrine insufficiency and replacement therapy in pancreatic cancer [PDF]
Pancreatic exocrine insufficiency (PEI) is highly prevalent in patients with pancreatic cancer, and has substantial implications for quality of life and survival.
de Liguori Carino, N. +2 more
core +1 more source
Objectives The aim of this study was to determine the prevalence of pancreatic exocrine insufficiency in patients with pancreatic or periampullary cancer, both before and after resection.
Tseng, DSJ +5 more
core +2 more sources
Diabetes mellitus and exocrine pancreatic insufficiency (review of literature)
Currently, an increasing importance is given to the study of the problem of exocrine pancreatic insufficiency, which is observed in a significant number of patients with diabetes mellitus (DM) type 1 and 2 and can potentially affect the compensation of ...
L.T. Daminova, S.U. Muminova
doaj +1 more source
Abstract Background Pancreatic enzyme insufficiency (PEI) contributes to symptom burden and malnutrition in advanced pancreatic cancer (aPC). We aimed to evaluate the impact of pancreatic enzyme replacement therapy (PERT) on symptom burden and weight during chemotherapy.
Pamela N. Klassen +6 more
wiley +1 more source

